Document is current
Any future updates will be listed below
-
Authors
Azuly, Hovav
Shafat, Tali
Grupel, Daniel
Porges, Tzvika
Abuhasira, Ran
Belkin, Ana
Deri, Ofir
Oster, Yonatan
Zahran, Shadi
Horwitz, Ehud
Horowitz, Netanel A.
Khatib, Hazim
Batista, Marjorie Vieira
Cortez, Anita Cassoli
Brosh-Nissimov, Tal
Segman, Yafit
Ishay, Linor
Cohen, Regev
Atamna, Alaa
Spallone, Amy
Chemaly, Roy F.
Ramos, Juan Carlos
Chowers, Michal
Rogozin, Evgeny
Oren, Noga Carmi
Keske, Şiran
Barchad, Orit Wolfovitz
Nesher, Lior https://orcid.org/0000-0002-1230-0428
,
Shafat, Tali
Batista, Marjorie Vieira
Atamna, Alaa
Spallone, Amy
Chemaly, Roy F.
Ramos, Juan Carlos
Keske, Şiran
Nesher, Lior https://orcid.org/0000-0002-1230-0428
- License Information
-
More Information
Article History
Received: 27 September 2024
Accepted: 20 November 2024
First Online: 9 December 2024
Declarations
:
: Tal Brosh-Nissimov reports honoraria for lectures and advisory board attendance from AstraZeneca, Gilead, MSD, and Medison; Lior Nesher reports honoraria for educational lectures from Pfizer, MSD, Moderna, AstraZeneca, and participation in advisory boards for MSD, Medison, and AstraZeneca. Roy F Chemaly reportsConsultant/Speaker/Advisor for ADMA Biologics, Janssen, Merck/MSD, Takeda, Shinogi, AiCuris, Roche/Genentech, Astellas, Tether, Oxford Immunotec, Karius, Moderna, InflaRX, and Ansun Pharmaceuticals. He received research grants paid to his institution from Merck/MSD, Karius, AiCuris, Ansun Pharmaceuticals, Takeda, Genentech, Oxford Immunotec, and Eurofins-Viracor. He also serves as a DSMC member for AstraZeneca All other authors (Hovav Azuly, Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Juan Carlos Ramos-Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske and Orit Wolfovitz Barchad) report no COI.
: The Soroka Ethics in Research Committee and each participating site's committee (see supplementary material) approved this study and granted a waiver of informed consent (SOR-22–0198).
